1Ruzicka T, Simmet T, Peskar BA, et al. Skin levels of arachidonic acidderived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol, 1986,86(2): 105-108.
2Kanai H, Nagashima A, Hirakata E, et al. The effect of azelastin hydrochloride on pruritus and leukotriene B4 in hemodialysis patients. Life Sci, 1995,57(3) :207-213.
3Andoh T, Kuraishi Y. Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice. Eur J Pharmacol, 1998,353(1) :93-96.
4Andoh T, Kuraishi Y. Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice. Eur J Pharmacol, 2000,406(1): 149-152.
5Heyer G, Vogelgsang M, Homstein OP. Acetylcholine is an inducer of itching in patients with atopic eczema. J Dermatol, 1997, 24 (10): 621-
6Steen KH, Reeh PW. Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro. J Neurophysiol, 1993,70(1 ):397-405.
7Abeck D, Andersson T, Grosshans E, et al. Topical application of a platelet-activating factor (PAF) antagonist in atopic dermatitis. Acta Derm Venereol, 1997,77(6) :449-451.
8Woodward DF, Nieves AL, Spada CS, et al. Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.J Pharmacol Exp Ther, 1995,272(2) :758-765.
9Petersen LJ, Church MK, Skor PS. Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade. J Allergy Clin Immunol, 1997,99(5) :640-647.
10Cremer B, Heimann A, Dippel E, et al. Pruritogenic effects of mitogenstimulated peripheral blood mononuclear cells in atopic eczema. Acta Derm Venereol, 1995,75(6) :426-428.
